Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical Sciences|November 14, 2014
A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolationChristoph Thiel, Sebastian Schneckener, Markus Krauss, et al.
BMB Reports|July 27, 2012
Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid loadJens Niklas, Anne Bonin, Stefanie Mangin, et al.
Metabolites|December 4, 2020
Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MSSylvia K Neef, Nicole Janssen, Stefan Winter, et al.
Pharmacogenetics and Genomics|May 3, 2005
Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17Mikko Niemi, Pertti J Neuvonen, Ute Hofmann, et al.
Analytical and Bioanalytical Chemistry|July 6, 2015
Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitorMathias Haag, Ute Hofmann, Thomas E Mürdter, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 24, 2004
Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out miceKari T Kivistö, Jörg Zukunft, Ute Hofmann, et al.
Scientific Reports|November 17, 2018
Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regenerationKerstin Abshagen, Bastian Degenhardt, Marie Liebig, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytesDiana M Feidt, Kathrin Klein, Ute Hofmann, et al.
Chemico-Biological Interactions|November 9, 2023
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cellsSofia Pagarin, Anna Bolognese, Stefano Fornasaro, et al.
Frontiers in Pharmacology|April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteersVanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Pageof 14